Efectos adversos inmunomediados por inhibidores de PD-1
Los anticuerpos monoclonales que inhiben los puntos de control PD-1 y CTLA-4 se usan actualmente en el tratamiento del melanoma y cáncer metastásico de pulmón de células no pequeñas, entre otros.
María Paz Micieli Galeazzi +7 more
doaj
[Controversies surrounding lung cancer screening]. [PDF]
Moreno-Bartolomé C +2 more
europepmc +1 more source
Los efectos adversos del masaje
openaire +2 more sources
[Dermal fillers and late-onset reactions: An emerging challenge in primary care]. [PDF]
Estalayo-Gutiérrez B +3 more
europepmc +1 more source
[Clinical and microbiological effectiveness of Helicobacter pylori eradication treatment with triple therapy]. [PDF]
Ghandour Fawaz Y +5 more
europepmc +1 more source
[Correlation of occlusion pressure with sedation in non-neurocritical patients]. [PDF]
Valadez-Andrade JA +3 more
europepmc +1 more source
[Ziresovir: a potent, selective, and oral inhibitor of the respiratory syncytial virus fusion (F) protein]. [PDF]
Reina J, Bosch-Durán J.
europepmc +1 more source
[Mediterranean Spotted Fever: A Case Report]. [PDF]
de Antonio Feu S +2 more
europepmc +1 more source
[The Usefulness of Neuromodulators in Clinical Practice: The Gastroenterologist's Viewpoint]. [PDF]
García-Zermeño KR +3 more
europepmc +1 more source
[Recommendations from an antimicrobial stewardship program on the duration of antibiotic treatment: effectiveness of short-course regimens in the emergency department]. [PDF]
Martínez-de La Cruz P +8 more
europepmc +1 more source

